Table 2.
Commercial diet | n-3PUFA diet | n-6PUFA diet | MUFA diet | |
---|---|---|---|---|
n-9 series | ||||
Oleic Acid | 17.5 ± 3.9a | 23 ± 3.3b | 19.6 ± 3.1a | 26.1 ± 3.2b |
n-6 series | ||||
LA | 11 ± 0.65a | 9.2 ± 1.2c | 11.7 ± 0.9a | 9.5 ± 1.3b |
ARA | 14.3 ± 2.1a | 14.2 ± 1.1a | 19.4 ± 1.3b | 15.8 ± 1.2a |
DPAn-6 | 0.56 ± 0.07b | 0.41 ± 0.08a | 1.22 ± 0.2c | 1.03 ± 0.2c |
n-3 series | ||||
ALA | 0.17 ± 0.04a | 0.37 ± 0.16b | 0.04 ± 0.02c | 0.04 ± 0.02c |
EPA | 0.36 ± 0.02a | 0.63 ± 0.07b | 0.06 ± 0.02d | 0.08 ± 0.02c |
DPAn-3 | 0.53 ± 0.2a | 0.75 ± 0.1b | 0.19 ± 0.03d | 0.33 ± 0.04c |
DHA | 5.79 ± 0.9a | 5.79 ± 0.9a | 3.79 ± 0.6b | 4.06 ± 0.7b |
n-6/n-3 ratio | ||||
ARA/DHA | 2.57 ± 0.6a | 2.45 ± 0.2a | 5.14 ± 0.3c | 3.92 ± 0.3b |
Note: Results are means ± SEM and are expressed as percents of the total fatty acid content of erythrocyte membrane phospholipids. Distinct and similar superscript letters (a, b, c and/or d) within a same horizontal line indicate significant (p<0.01) and not significant differences between dietary groups towards the considered fatty acid, respectively. Abbreviations are: LA, linoleic acid; ARA, arachidonic acid; DPAn-6, docosapentaenoic acid of the n-6 series; ALA, alpha-linolenic acid; EPA, eicosapentanoic acid; DPAn-3, docosapentaenoic acid of the n3 series, DHA, docosahexaenoic acid. Diets have been defined in the text and in Table 1 and have been given to mice for a period 30 days before analyses of erythrocyte membrane phospholipids. Contents in phospholipid saturated fatty acids are 100% from which are withdrawn percentages of phospholipid unsaturated fatty acids given in the table.